News
Kyntra Bio
KYNB · NASDAQ
$5.28+$0.00 (+0.00%)TodayMarket closed ·
Prev close $5.28
Latest news
- Press releaseGlobe Newswire
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
- News
Kyntra Bio Q1 EPS $(3.76) Down From $1.15 YoY, Sales $3.738M Up From $2.739M YoY
- Press releaseGlobe Newswire
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
- News
Earnings Scheduled For May 11, 2026
- Press releaseGlobe Newswire
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- News
Earnings Scheduled For March 16, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.